HYDROXAMIC ACID AND ITS DERIVATIVES AS INHIBITORS OF MELANOCYTE TYROSINASE FOR TOPICAL SKIN LIGHTENERS

Details for Australian Patent Application No. 2002364203 (hide)

Owner INTEGRIDERM, INC.

Inventors DOOLEY, Thomas P.; CHENG, Lin

Pub. Number AU-A-2002364203

PCT Number PCT/US02/41071

PCT Pub. Number WO2003/057184

Priority 60/344,464 28.12.01 US

Filing date 23 December 2002

Wipo publication date 24 July 2003

International Classifications

A61K 007/48

A61K 031/16 - Amides, e.g. hydroxamic acids

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/344,464 28.12.01 US

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002364203

12 August 2004 Assignment before Grant

  Integriderm, Inc. The application has been assigned to MediQuest Therapeutics, Inc. 2003

1 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364204-Methods and apparatus for encapsulating a frame for transmission in a storage area network

2002364202-METATASIS SUPPRESSOR GENE ON HUMAN CHROMOSOME 8 AND ITS USE IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER